List of articles with "South San Francisco"

IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

USA NASDAQ stock options IDEAYA Biosciences South San Francisco
Rigel Settles TAVALISSE Patent Case

Rigel Settles TAVALISSE Patent Case

United States South San Francisco Rigel Pharmaceuticals TAVALISSE Annora Pharma
Human Longevity's Cancer Initiative

Human Longevity's Cancer Initiative

United States South San Francisco Precision Medicine Prostate Cancer Human Longevity
Vaccine Collaboration

Vaccine Collaboration

USA South San Francisco Universal Vaccine Centivax Emery Pharma
Dr. Frohlich Joins Rigel

Dr. Frohlich Joins Rigel

USA oncology South San Francisco Rigel Pharmaceuticals Mark Frohlich
ESSA Pharma Meeting

ESSA Pharma Meeting

USA ESSA Pharma South San Francisco Prostate Cancer David Parkinson
Rigel's 2024 Financial Success

Rigel's 2024 Financial Success

USA South San Francisco Rigel Pharmaceuticals TAVALISSE REZLIDHIA
Leadership Changes at 3T

Leadership Changes at 3T

United States South San Francisco 3T Biosciences Marvin Gee Barbara Sennino
Breakthrough Drug Discovery

Breakthrough Drug Discovery

United States oncology South San Francisco IDEAYA ATTMOS
IDEAYA Inducement Grants

IDEAYA Inducement Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Mytra Hires Tesla's CFO

Mytra Hires Tesla's CFO

USA Tesla South San Francisco Mytra Gabi Gantus
Perceive Pharma Funding

Perceive Pharma Funding

USA South San Francisco ophthalmology glaucoma Perceive Pharma
New Study on NSCLC

New Study on NSCLC

United States South San Francisco IDEAYA Gilead Trodelvy
IDEAYA Biosciences Update

IDEAYA Biosciences Update

USA oncology IDEAYA Biosciences South San Francisco darovasertib
ESSA Pharma's Q1 Update

ESSA Pharma's Q1 Update

United States ESSA Pharma South San Francisco Prostate Cancer masofaniten
Joshua Bleharski Joins IDEAYA

Joshua Bleharski Joins IDEAYA

United States biotechnology IDEAYA Biosciences South San Francisco Joshua Bleharski
IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Tahoe-100M Open Source

Tahoe-100M Open Source

United States South San Francisco NVIDIA Vevo Therapeutics Tahoe-100M
Revolutionizing Sleep Health

Revolutionizing Sleep Health

United States Sleep Health South San Francisco Human Longevity SleepScore Labs
Rigel Pharmaceuticals Update

Rigel Pharmaceuticals Update

USA South San Francisco Rigel Pharmaceuticals TAVALISSE REZLIDHIA
IDEAYA at J.P. Morgan

IDEAYA at J.P. Morgan

USA J.P. Morgan IDEAYA Biosciences South San Francisco Precision Medicine
Rigel's R289 Receives FDA Designation

Rigel's R289 Receives FDA Designation

United States South San Francisco Rigel Pharmaceuticals R289 MDS
Rigel Grants Stock Options

Rigel Grants Stock Options

United States stock options South San Francisco Rigel Pharmaceuticals RIGL
IDEAYA and Hengrui Collaboration

IDEAYA and Hengrui Collaboration

United States South San Francisco IDEAYA Hengrui Pharma SHR-4849
Strategic Stock Options Grant

Strategic Stock Options Grant

United States stock options IDEAYA Biosciences South San Francisco Precision Medicine
ESSA Pharma Update

ESSA Pharma Update

United States ESSA Pharma South San Francisco Prostate Cancer masofaniten
IDEAYA Nominates IDE251

IDEAYA Nominates IDE251

USA South San Francisco IDEAYA IDE251 KAT6/7
Investor R&D Day Agenda

Investor R&D Day Agenda

USA oncology South San Francisco Precision Medicine IDEAYA
IDE161 and KEYTRUDA Trial

IDE161 and KEYTRUDA Trial

USA IDEAYA Biosciences South San Francisco IDE161 KEYTRUDA
IDE892: New Cancer Breakthrough

IDE892: New Cancer Breakthrough

USA IDEAYA Biosciences South San Francisco PRMT5 Inhibitor IDE892
IDEAYA Inducement Grants

IDEAYA Inducement Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Largest Drug Interaction Atlas

Largest Drug Interaction Atlas

United States South San Francisco Vevo Therapeutics Tahoe-100M Mosaic platform
FDA Fast Track for R289

FDA Fast Track for R289

United States South San Francisco Rigel Pharmaceuticals R289 MDS
IDEAYA's December Events

IDEAYA's December Events

USA oncology IDEAYA Biosciences South San Francisco targeted therapies
IDEAYA Stock Options Grant

IDEAYA Stock Options Grant

United States stock options IDEAYA Biosciences Nasdaq rule South San Francisco

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.